Neurogene Inc. - Common Stock (NQ: NGNE )

33.40 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	33.40
Bid (Size)	30.51 (1)
Ask (Size)	36.24 (1)
Prev. Close	33.40
Today's Range	33.40 - 33.40
52wk Range	12.49 - 53.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting

April 22, 2024

From Neurogene Inc.

Via Business Wire

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

April 12, 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

Via InvestorPlace

Performance

YTD	+68.09%	+68.09%
1 Month	-28.60%	-28.60%
3 Month	+4.37%	+4.37%
6 Month	+121.19%	+121.19%
1 Year	+121.19%	+121.19%

More News

Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates

March 18, 2024

From Neurogene Inc.

Via Business Wire

Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial

March 04, 2024

From Neurogene Inc.

Via Business Wire

MicroMarvel Neurogene Challenges Big Pharma

January 22, 2024

Via Talk Markets

Neurogene to Participate in Upcoming Investor Conferences

February 29, 2024

From Neurogene Inc.

Via Business Wire

Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer

January 16, 2024

From Neurogene Inc.

Via Business Wire

Neurogene Announces Business Update and 2024 Outlook

January 05, 2024

From Neurogene Inc.

Via Business Wire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.